All reagents are required to perform blood testing for medical laboratory
Ended Awarded Last action
- Contract number
- HT009026FG1230022
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $24,547
Award facts
- Contract value 100% obligated
- $24,547.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $24,547.20 firm fixed-price call order to Roche Diagnostics Corporation for blood testing reagents required to perform medical laboratory testing. The award, issued on December 19, 2025, is scheduled for completion by September 30, 2026, and represents a child contract under a larger blanket purchase agreement vehicle. The work will be performed at Roche's facility in Castleton, Indiana. No set-aside designation was applied to this procurement, indicating open competition in the federal marketplace.
This call order is consistent with Roche Diagnostics' extensive federal contracting portfolio, which includes multiple active indefinite delivery contracts and blanket purchase agreements with the Defense Health Agency and Department of Veterans Affairs. Roche maintains a $606,000 BPA with the Defense Health Agency for chemistry analyzers and reagents on a cost-per-reportable-result basis, along with several larger indefinite delivery contracts for reagents, consumables, and maintenance services supporting fully automated laboratory systems. The company's established presence as a primary supplier of advanced diagnostic capabilities to military and federal healthcare systems positions it to efficiently fulfill this reagent requirement through pre-negotiated pricing and established contractual terms.
Quick answers
Who was awarded contract HT009026FG1230022?
HT009026FG1230022 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on December 19, 2025.
How much is contract HT009026FG1230022 worth?
The government has obligated $24,547 on HT009026FG1230022.
Is contract HT009026FG1230022 an order under another contract?
Yes. HT009026FG1230022 is a BPA call under FA301625A0005, a blanket purchase agreement.
Was contract HT009026FG1230022 competed?
The extent of competition for HT009026FG1230022 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award